Cargando…
Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
Autores principales: | Nair, Abhijit S, Mantha, Srinivasa Shyam Prasad, Kumar, Kodisharapu Praveen, Rayani, Basanth Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812433/ https://www.ncbi.nlm.nih.gov/pubmed/31673220 http://dx.doi.org/10.4103/IJPC.IJPC_41_19 |
Ejemplares similares
-
Feasibility and efficacy of sublingual buprenorphine tablets in managing acute postoperative pain after elective breast cancer surgeries: A series of 10 cases
por: Sumanth, D Krishna, et al.
Publicado: (2019) -
A randomized controlled study to compare analgesic efficacy of sublingual buprenorphine and intravenous tramadol in patients undergoing mastectomy
por: Dokku, Krishna Sumanth, et al.
Publicado: (2022) -
Pericapsular Nerve Group Block as an Effective Intervention for Pain Relief and Improving Functional Mobility in Cancer Patients: A Case Series
por: Mantha, Srinivasa Shyam Prasad, et al.
Publicado: (2023) -
Continuous trans-muscular quadratus lumborum block for patient with postscoliosis correction undergoing open adrenalectomy - A case report
por: Mantha, Srinivas Shyam Prasad, et al.
Publicado: (2021) -
Lidocaine 5% Patch in Localized Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)